Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
XNW-1011 by SinoMab Bioscience for Systemic Lupus Erythematosus: Likelihood of Approval
XNW-1011 is under clinical development by SinoMab Bioscience and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData,...